CERAMENT™| Bone Void Filler Device Registry
← catalyst calendarNCT04244942 · readout in 586 d
Sponsored by BONESUPPORT AB (industry) · BONEX.ST — their whole pipeline →.
Phase
—
Status
Recruiting
Study type
Observational
Enrollment
300estimated
Sites
13
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-21
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2020-03-30 | actual | When the study began enrolling |
| Primary completion | 2028-03-30 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2028-03-30 | estimated | The whole study's end, after follow-up |
| First posted | 2020-01-28 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-09-29 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Orthopedic Disorder
Intervention
- Device: CERAMENT BVF
Primary outcomes
what the primary-completion date above is the date OFUnexpected device performance will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 18 months
measured 12 months
Unexpected device performance will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 18 months
measured 18 months
Complaints will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 18 months
measured 12 months
Complaints will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 18 months
measured 18 months
Adverse events will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 18 months
measured 12 and 18 months
Adverse events will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 18 months
measured 12 months
adverse device events will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 18 months
measured 18 months
SAEs will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 18 months
measured 12 months
SAEs will be collected as they occur at time of surgery and on an ongoing basis thereafter, with formal scheduled review at 12 and 18 months
measured 18 months
Permalink · BONEX.ST's whole pipeline · Catalyst calendar · Every registered study · What changed